CP
Therapeutic Areas
Unnatural Products Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Internal Portfolio | Undisclosed high-value biology | Pre-clinical |
| Cardiovascular Collaboration | Cardiovascular Diseases | Discovery |
| Oncology Target Collaboration | Oncology (intracellular target) | Discovery/Optimization |
| Immunology Collaboration | Immunology (oral targets) | Discovery |
| Rare Disease Collaboration | Rare Disease | Discovery/Optimization |